CPAP APAP denied as not FDA-approved for this use by Humana?

Humana's specific coverage criteria for cpap apap are defined in its own published medical/coverage policy and the FDA-approved prescribing label. A successful appeal documents that your medical records satisfy each criterion those sources list — confirmed diagnosis, any required prior treatments (with dates and outcomes), and clinical severity. If the exact criteria weren't included with your denial, request them in writing; your appeal then maps each requirement to the matching fact in your chart.

## Why Humana Denied Your CPAP/APAP as "Not FDA-Approved" — and How to Appeal

This denial is almost always a coding or documentation mismatch rather than a genuine device-approval problem. CPAP and APAP devices are FDA-cleared Class II medical devices for the treatment of obstructive sleep apnea (OSA). A "not FDA-approved" denial in the durable medical equipment (DME) context typically means either (a) the device was billed under a code that does not match the ordered equipment, (b) the specific device model was not on Humana's approved DME supplier list, or (c) the documentation submitted did not clearly establish the diagnosis that the device is indicated for.

## Why This Denial Is Appealable

Because CPAP and APAP are established, FDA-cleared treatments for OSA, a blanket "not FDA-approved" characterization is factually incorrect for any device lawfully marketed in the United States. The appeal should establish the regulatory status of the specific device and tie it directly to the documented diagnosis.

## Federal Appeal Framework

• ERISA §503: If your plan is employer-sponsored, you have the right to a full-and-fair internal review with a written explanation of the denial criteria.
• ACA §2719 / External Review: After exhausting internal appeals, you may request an Independent Review Organization (IRO) review. The standard window to request external review is generally within four months of the final internal denial — check your denial letter for the exact deadline.
• Expedited review: If your condition is urgent or ongoing treatment is at risk, request expedited (72-hour) external review.

## Concrete Appeal Steps and Timeline

1. Request the complete denial letter and your plan's Summary Plan Description (SPD) or Evidence of Coverage (EOC) within 5 days of receiving the denial. 2. Obtain a copy of Humana's current DME coverage policy for CPAP/APAP — available on Humana's website or on request. 3. Submit your Level 1 internal appeal within the deadline stated on the denial letter (typically 180 days). 4. If the internal appeal is denied, file for external review within the four-month window.

## Documentation to Gather

• Diagnosis confirmation: Sleep study (polysomnogram or home sleep apnea test) report showing the OSA diagnosis, signed by the ordering provider.
• Device FDA clearance: The device manufacturer's 510(k) clearance number or FDA device listing — your DME supplier can provide this.
• Prescription/order: A current, valid order from a licensed provider specifying CPAP or APAP and the clinical indication.
• Supplier credentials: Confirmation that the DME supplier is enrolled in Humana's network or that a network-exception applies.
• Medical-necessity letter: A letter from your prescribing physician stating the diagnosis, why CPAP/APAP is indicated, and that the ordered device is an FDA-cleared treatment for OSA.

## Criteria-Mapping Structure

Pull every requirement listed in Humana's DME/CPAP coverage policy. For each requirement, write one sentence citing the exact supporting document in your file — for example: "Policy requires documented OSA diagnosis via sleep study → [Date] polysomnogram from [Lab] confirms diagnosis, attached as Exhibit A." Attach the FDA clearance letter for the specific device model alongside the mapping table.